Author : Syvak L.
Effect of chemokin polymorphisms on the efficacy of chemotherapy in patients with Her2/neu-negative breast cancerAuthors: Syvak L. Verovkina N.O. Lyalkin S. Tarasenko T.... Т. 11, № 3-4 (43-44)
Prognostic factors of metastatic luminal (Her2/neu-negative) breast cancerAuthors: Tarasenko T. Syvak L. Verevkina N. Lyalkin S.... T. 10, № 1-2 (37-38)
